Tuesday, December 1, 2020
4:00pm PT | 7:00pm ET | 8:00pm AT
International Expert: Nick James
Canadian KOL: Ricardo Rendon
1. Review current treatment options for the management of mHSPC
2. Discuss recent updates on long term followup of the stampede cohorts
3. Highlight the evolving management of low and high volume mHSPC
SERIES SPONSOR: Janssen
Specific Sponsors: Amgen, Abbvie, AstraZeneca, Sanofi
Accredited for Section 1 Credits √
Questions? Contact Tal at the CUA - firstname.lastname@example.org
NOTE: For members who would like this activity recorded in their profile, please use the email that is associated with your CUA membership.
***This webinar is reserved for healthcare professionals and sponsoring companies.
Registration will be vetted before event links are provided to participants.***
Ce programme est disponible en anglais seulement.